EI
FMI

EAM Investors’s Foundation Medicine, Inc. FMI Stock Holding History

EAM Investors’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,287
Closed -$647K – 388
2017
Q2 		$647K Sell
16,287
-6,419
-28% -$235K 0.11% 242
2017
Q1 		$732K Buy
+22,706
New +$566K 0.12% 239

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
DGI
Discovery Group I Chicago, Illinois $262M AUM 29.24% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

EAM Investors's FMI Position: Q3 2017 in Review

EAM Investors sold out of Foundation Medicine, Inc. (FMI) in Q3 2017, closing a stake of 16,287 shares — an estimated $647K sold.

EAM Investors first reported a position in FMI in Q1 2017 and held it in 2 quarters. The position peaked at $732K in Q1 2017. 97 funds tracked by Wall St. Rank hold FMI as of Q3 2017.

  • EAM Investors reported no remaining Foundation Medicine, Inc. position as of Q3 2017 after selling out during the quarter.
  • EAM Investors sold 16,287 Foundation Medicine, Inc. shares in Q3 2017, an estimated $647K.
  • EAM Investors first reported a position in Foundation Medicine, Inc. in Q1 2017 and held it in 2 quarters.
  • EAM Investors's Foundation Medicine, Inc. position peaked at $732K in Q1 2017.
  • 97 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2017.

Based on EAM Investors's 13F filing for Q3 2017, filed 8 Nov 2017.